Phillips Medisize Acquires Chippenham Facility to Expand Global Inhalation Center of Excellence

CHIPPENHAM, England & HUDSON, Wis.–(BUSINESS WIRE)– #Biologics–Phillips Medisize, a Molex company and a leader in the design, development, engineering and manufacturing of pharmaceutical drug delivery, in vitro diagnostic and medtech devices, today announced an investment to acquire the complete footprint of its Chippenham site. Together with its Cambridge location, the newly acquired facility strengthens the company’s Global Inhalation Center of Excellence (COE) and provides additional capacity to suppo

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.